A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of GEMOX(Gemcitabine/Oxaliplatin) vs XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma.
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 15 Feb 2017 Planned End Date changed from 1 Jul 2012 to 1 Dec 2018.
- 15 Feb 2017 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2017.
- 03 Feb 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.